| Affymax, Takeda report Phase 3 data for anemia drug in dialysis patients - NephrOnline |
|
|
NephrOnline These data, along with a demographic analysis from the dialysis studies, were part of three poster presentations at the National Kidney Foundation's Spring Clinical Meetings in Las Vegas. The primary efficacy endpoint for both studies was the ... Takeda, Affymax announce additional peginesatide Phase 3 study results in |